Algeta Appoints Dr Andreas Menrad as Chief Scientific Officer

03:01 EDT 19 Aug 2013 | GlobalNewsWire (2014)
This article has expired, however you can still download the PDF.
Preview:
Oslo, Norway, 19th August 2013 - Algeta ASA (OSE: ALGETA), a company focused on the development of novel targeted cancer therapeutics, is pleased to announce the appointment of Dr Andreas Menrad as Chief Scientific Officer (CSO) and member of the e...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "Algeta Appoints Dr Andreas Menrad as Chief Scientific Officer "

Search BioPortfolio:
Loading
Advertisement

Relevant Topics

Biotechnology - Biotech
Latest News Clinical Trials Research Drugs Reports Corporate
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Cancer
Latest News Clinical Trials Research Drugs Reports Corporate
Cancer is a condition where cells in a specific part of the body grow and reproduce uncontrollably. The cancerous cells can invade and destroy surrounding healthy tissue, including organs.  Cancer sometimes begins in one part of the body before spre...

Advertisement

Searches Linking to this Story